Multiple Doses of AT-1501-A201 in Adults With ALS

Clinical trial NCT04322149 · COMPLETED

Trial details

NCT number: NCT04322149
Sponsor: Anelixis Therapeutics, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-10-16
Primary completion: 2022-03-24
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.